Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 491

1.

Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial.

Nobile-Orazio E, Cocito D, Jann S, Uncini A, Beghi E, Messina P, Antonini G, Fazio R, Gallia F, Schenone A, Francia A, Pareyson D, Santoro L, Tamburin S, Macchia R, Cavaletti G, Giannini F, Sabatelli M; IMC Trial Group.

Lancet Neurol. 2012 Jun;11(6):493-502. doi: 10.1016/S1474-4422(12)70093-5. Epub 2012 May 10.

PMID:
22578914
2.

Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy.

Eftimov F, Winer JB, Vermeulen M, de Haan R, van Schaik IN.

Cochrane Database Syst Rev. 2013 Dec 30;(12):CD001797. doi: 10.1002/14651858.CD001797.pub3. Review.

PMID:
24379104
3.
4.

Frequency and time to relapse after discontinuing 6-month therapy with IVIg or pulsed methylprednisolone in CIDP.

Nobile-Orazio E, Cocito D, Jann S, Uncini A, Messina P, Antonini G, Fazio R, Gallia F, Schenone A, Francia A, Pareyson D, Santoro L, Tamburin S, Cavaletti G, Giannini F, Sabatelli M, Beghi E; IMC Trial Group.

J Neurol Neurosurg Psychiatry. 2015 Jul;86(7):729-34. doi: 10.1136/jnnp-2013-307515. Epub 2014 Sep 22.

PMID:
25246645
5.

Randomised controlled trial of methotrexate for chronic inflammatory demyelinating polyradiculoneuropathy (RMC trial): a pilot, multicentre study.

RMC Trial Group.

Lancet Neurol. 2009 Feb;8(2):158-64. doi: 10.1016/S1474-4422(08)70299-0. Epub 2009 Jan 10.

PMID:
19136303
6.

Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy.

Mendell JR, Barohn RJ, Freimer ML, Kissel JT, King W, Nagaraja HN, Rice R, Campbell WW, Donofrio PD, Jackson CE, Lewis RA, Shy M, Simpson DM, Parry GJ, Rivner MH, Thornton CA, Bromberg MB, Tandan R, Harati Y, Giuliani MJ; Working Group on Peripheral Neuropathy.

Neurology. 2001 Feb 27;56(4):445-9.

PMID:
11222785
7.

Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy.

Eftimov F, Winer JB, Vermeulen M, de Haan R, van Schaik IN.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD001797. doi: 10.1002/14651858.CD001797.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;12:CD001797.

PMID:
19160200
8.

Intramuscular interferon beta-1a in chronic inflammatory demyelinating polyradiculoneuropathy.

Hughes RA, Gorson KC, Cros D, Griffin J, Pollard J, Vallat JM, Maurer SL, Riester K, Davar G, Dawson K, Sandrock A; Avonex CIDP Study Group.

Neurology. 2010 Feb 23;74(8):651-7. doi: 10.1212/WNL.0b013e3181d1a862.

PMID:
20177118
9.

Treatment of chronic inflammatory demyelinating polyneuropathy with high dose intravenous methylprednisolone monthly for five years: 10-Year follow up.

Börü ÜT, Erdoğan H, Alp R, Taşdemir M, Yıldırım S, Bilgiç A, Duman A, Arslan A.

Clin Neurol Neurosurg. 2014 Mar;118:89-93. doi: 10.1016/j.clineuro.2014.01.001. Epub 2014 Jan 14.

PMID:
24529237
10.

Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy.

Hughes R, Bensa S, Willison H, Van den Bergh P, Comi G, Illa I, Nobile-Orazio E, van Doorn P, Dalakas M, Bojar M, Swan A; Inflammatory Neuropathy Cause and Treatment (INCAT) Group.

Ann Neurol. 2001 Aug;50(2):195-201.

PMID:
11506402
11.

Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy: the ICE trial.

Hughes RA.

Expert Rev Neurother. 2009 Jun;9(6):789-95. doi: 10.1586/ern.09.30. Review.

PMID:
19496683
12.
13.

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (The PATH Study): study protocol for a randomized controlled trial.

van Schaik IN, van Geloven N, Bril V, Hartung HP, Lewis RA, Sobue G, Lawo JP, Mielke O, Cornblath DR, Merkies IS; PATH study group.

Trials. 2016 Jul 25;17(1):345. doi: 10.1186/s13063-016-1466-2.

14.

Pulsed high-dose dexamethasone versus standard prednisolone treatment for chronic inflammatory demyelinating polyradiculoneuropathy (PREDICT study): a double-blind, randomised, controlled trial.

van Schaik IN, Eftimov F, van Doorn PA, Brusse E, van den Berg LH, van der Pol WL, Faber CG, van Oostrom JC, Vogels OJ, Hadden RD, Kleine BU, van Norden AG, Verschuuren JJ, Dijkgraaf MG, Vermeulen M.

Lancet Neurol. 2010 Mar;9(3):245-53. doi: 10.1016/S1474-4422(10)70021-1. Epub 2010 Feb 2.

PMID:
20133204
15.

Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy.

Van Schaik IN, Winer JB, De Haan R, Vermeulen M.

Cochrane Database Syst Rev. 2002;(2):CD001797. Review. Update in: Cochrane Database Syst Rev. 2009;(1):CD001797.

PMID:
12076423
16.

Randomised controlled trial comparing two different intravenous immunoglobulins in chronic inflammatory demyelinating polyradiculoneuropathy.

Kuitwaard K, van den Berg LH, Vermeulen M, Brusse E, Cats EA, van der Kooi AJ, Notermans NC, van der Pol WL, van Schaik IN, van Nes SI, Hop WC, van Doorn PA.

J Neurol Neurosurg Psychiatry. 2010 Dec;81(12):1374-9. doi: 10.1136/jnnp.2010.206599. Epub 2010 Jun 28.

PMID:
20587484
17.

A multicentre randomiSed controlled TRial of IntraVEnous immunoglobulin compared with standard therapy for the treatment of transverse myelitis in adults and children (STRIVE).

Absoud M, Brex P, Ciccarelli O, Diribe O, Giovannoni G, Hellier J, Howe R, Holland R, Kelly J, McCrone P, Murphy C, Palace J, Pickles A, Pike M, Robertson N, Jacob A, Lim M.

Health Technol Assess. 2017 May;21(31):1-50. doi: 10.3310/hta21310.

18.

Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trial.

Hughes R, Dalakas MC, Merkies I, Latov N, Léger JM, Nobile-Orazio E, Sobue G, Genge A, Cornblath D, Merschhemke M, Ervin CM, Agoropoulou C, Hartung HP; FORCIDP Trial Investigators.

Lancet Neurol. 2018 Aug;17(8):689-698. doi: 10.1016/S1474-4422(18)30202-3. Epub 2018 Jul 9. Erratum in: Lancet Neurol. 2018 Nov;17(11):933.

PMID:
30001923
19.

Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial.

Hughes RA, Donofrio P, Bril V, Dalakas MC, Deng C, Hanna K, Hartung HP, Latov N, Merkies IS, van Doorn PA; ICE Study Group.

Lancet Neurol. 2008 Feb;7(2):136-44. doi: 10.1016/S1474-4422(07)70329-0. Erratum in: Lancet Neurol. 2008 Sep;7(9):771.

PMID:
18178525
20.

Treatment of chronic inflammatory demyelinating polyneuropathy with pulsed oral steroids.

Muley SA, Kelkar P, Parry GJ.

Arch Neurol. 2008 Nov;65(11):1460-4. doi: 10.1001/archneur.65.11.1460.

PMID:
19001164

Supplemental Content

Support Center